Literature DB >> 12722939

Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma.

A Agarwal1, M Rani, G K Saha, T M Valarmathi, S Bahadur, B K Mohanti, Satya N Das.   

Abstract

It has been seen that advanced stage oral squamous cell carcinoma is associated with impaired T-cell function and higher antibody response. In order to find out if such immune disregulation is associated with alteration of T-helper (Th) type CD4+ T-cell phenotype leading to altered cytokine production, we studied the Th-like cytokine profile in 35 oral squamous cell carcinoma patients and 21 normal controls. Concomitant expression of both Th1 and Th2 cytokine genes was studied by reverse transcription and Polymerase Chain Reaction (PCR) based amplification (RT-PCR) of mRNA extracted from freshly isolated peripheral blood mononuclear cells (PBMC) using specific primers for Interferon (IFN)-gamma, Interleukin (IL)-2, IL-4 and IL-10. Almost 63% of oral cancer patients showed polarization of a Th-like cytokine response as compared to 33% of the normal controls while 66.6% of normal controls showed a predominantly non-polarized Th0 response. Expression of IFN-gamma and IL-2 genes was more commonly seen in the early stage of the disease (p < 0.02) whereas majority of advanced stage tumours was associated with enhanced expression of IL-4 and IL-10 but not IFN-gamma and IL-2 genes. Patients with lymphnode metastases and poorly differentiated tumours expressed IL-4 and IL-10 more frequently with concomitant suppression of IFN-gamma and IL-2 genes. It seems therefore, that the development of oral squamous cell carcinoma leads to polarization of cytokine gene expression that is skewed towards the Th1-like response in the early stage. However, increasing tumour load and lymphnode invasion suppresses Th1 cytokine genes, thus skewing it toward a Th2-like cytokine response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12722939     DOI: 10.1081/imm-120019205

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  15 in total

1.  Significant association of the cytokine variants with head and neck cancer risk: evidence from meta-analysis.

Authors:  Ting-Ting Xiao; Xian Li; Ying Xu; Yong Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-28       Impact factor: 2.503

2.  Polyfunctionality of CD4+ T lymphocytes is increased after chemoradiotherapy of head and neck squamous cell carcinoma.

Authors:  J Doescher; S Jeske; S E Weissinger; C Brunner; S Laban; E Bölke; T K Hoffmann; T L Whiteside; P J Schuler
Journal:  Strahlenther Onkol       Date:  2018-04-16       Impact factor: 3.621

3.  Tumour-Associated Tissue Eosinophilia in Oral Squamous Cell Carcinoma- A Boon or a Bane?

Authors:  Shweta Yellapurkar; Srikant Natarajan; Karen Boaz; Mohan Baliga; Premalatha Shetty; Nidhi Manaktala; Mukul Prasad; Mahalakshmi Ravi
Journal:  J Clin Diagn Res       Date:  2016-04-01

4.  T regulatory cell markers in oral squamous cell carcinoma: Relationship with survival and tumor aggressiveness.

Authors:  Geane Moreira; Lívia Bonfim Fulgêncio; Elismauro Francisco DE Mendonça; Cláudio Rodrigues Leles; Aline Carvalho Batista; Tarcília Aparecida DA Silva
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

5.  Skewed immunological balance between Th17 (CD4(+)IL17A (+)) and Treg (CD4 (+)CD25 (+)FOXP3 (+)) cells in human oral squamous cell carcinoma.

Authors:  Poonam Gaur; Gulam Abdul Qadir; Shilpy Upadhyay; Avadhesh Kumar Singh; Nootan Kumar Shukla; Satya Narayan Das
Journal:  Cell Oncol (Dordr)       Date:  2012-09-07       Impact factor: 6.730

6.  Role of interleukin-18 in modulation of oral carcinoma cell proliferation.

Authors:  Athip Nilkaeo; Suthinee Bhuvanath
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

7.  Response of lymphocyte subsets and cytokines to Shenyang prescription in Sprague-Dawley rats with tongue squamous cell carcinomas induced by 4NQO.

Authors:  Canhua Jiang; Dongxia Ye; Weiliu Qiu; Xiuli Zhang; Zhiyuan Zhang; Di He; Ping Zhang; Wantao Chen
Journal:  BMC Cancer       Date:  2007-03-05       Impact factor: 4.430

8.  Association between interleukin-4 gene intron 3 VNTR polymorphism and cancer risk.

Authors:  Yin Duan; Chi Pan; Jinan Shi; Hailong Chen; Suzhan Zhang
Journal:  Cancer Cell Int       Date:  2014-11-30       Impact factor: 5.722

9.  Eosinophils and oral squamous cell carcinoma: a short review.

Authors:  C P Martinelli-Kläy; B R R N Mendis; T Lombardi
Journal:  J Oncol       Date:  2009-12-16       Impact factor: 4.375

10.  Lentiviral vector-based therapy in head and neck cancer (Review).

Authors:  Deepak Upreti; Alok Pathak; Sam K P Kung
Journal:  Oncol Lett       Date:  2013-11-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.